z-logo
Premium
Sphingosine 1‐phosphate induces platelet/endothelial cell adhesion molecule‐1 phosphorylation in human endothelial cells through cSrc and Fyn
Author(s) -
Huang YuTing,
Lee Hsinyu
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.964.36
Subject(s) - fyn , microbiology and biotechnology , tyrosine phosphorylation , sphingosine 1 phosphate , phosphorylation , endothelial stem cell , proto oncogene tyrosine protein kinase src , lyn , human umbilical vein endothelial cell , integrin , biology , chemistry , sphingosine , receptor , biochemistry , in vitro
Sphingosine 1‐phosphate (S1P) is a multifunctional lysophospholipid. Through binding with a specific family of G protein‐coupled receptors, S1P activates various cellular functions in endothelial cells. Platelet/endothelial cell adhesion molecule‐1 (PECAM‐1) is a 130‐kDa transmembrane protein expressed predominantly on the surface of platelets and endothelial cells. Upon activation, the cytoplasmic tyrosine residues could be phosphorylated and regulate several cellular functions, including endothelial integrin activation and diapedesis. In this study, we first demonstrated that S1P induced PECAM‐1 tyrosine phosphorylation in human umbilical cord vein cells (HUVEC) by immunoprecipitation and western blot. The induction was blocked by pertussis toxin and PP2, the inhibitor for G i and Src family kinases (SFK). In addition, S1P‐induced SFK activation at endothelial cell borders was also observed by western blot and confocal microscopy. Two members of SFK, cSrc and Fyn, were dominantly expressed in HUVEC and targeted with specific siRNA. The induction effect of S1P on PECAM‐1 tyrosine phosphorylation was significantly suppressed in HUVEC cotrasfected with both siRNA. These results would help to elucidate the regulatory mechanism of S1P in PECAM‐1 functions in human endothelial cells.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here